Interpretable precision medicine for acute myeloid leukemia
Precision medicine (PM) is a branch of medicine that defines a disease at a higher resolution using genetic and other technologies to enable more specific targeting of its subgroups. Because of its uses in clinical treatment and diagnostics, this field exemplifies the modern era of medicine. PM l...
Main Authors: | Gimeno-Combarro, M. (Marian), Rubio-Díaz-Cordovés, Á. (Ángel), Carazo-Melo, F.(Fernando) |
---|---|
Format: | info:eu-repo/semantics/doctoralThesis |
Language: | eng |
Published: |
Servicio de Publicaciones. Universidad de Navarra
2023
|
Subjects: | |
Online Access: | https://hdl.handle.net/10171/65641 |
Similar Items
-
Synergistic effect of novel HDAC inhibitors with chemotherapy drugs in acute myeloid leukemia
by: Giménez-Camino, N. (Naroa), et al.
Published: (2022) -
Understanding niche-leukemia interactions: the bone marrow microenvironment regulates the metabolic and redox balance in acute myeloid leukemia stem cells
by: Ana Cristina, et al.
Published: (2023) -
DrugSniper, a Tool to Exploit Loss-Of-Function Screens, Identifies CREBBP as a Predictive Biomarker of VOLASERTIB in Small Cell Lung Carcinoma (SCLC)
by: Carazo-Melo, F.(Fernando), et al.
Published: (2023) -
Comparative pharmacology of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia
by: Azanza, J.R. (José Ramón), et al.
Published: (2022) - The Leukemias: etiology, pathophysiology, and treatment